Cover Image
Market Research Report

Europe Sleep Apnea Diagnostic and Therapeutic Market Forecast 2019-2027

Published by Inkwood Research Product code 802171
Published Content info 77 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Sleep Apnea Diagnostic and Therapeutic Market Forecast 2019-2027
Published: March 9, 2019 Content info: 77 Pages
Description

KEY FINDINGS

The most common symptoms of sleep apnea are daytime sleepiness, loud snoring, and restless sleep. The Europe market for sleep apnea diagnostic and therapeutic market is expected to grow at a CAGR of 6.15% from 2019-2027. Germany, the United Kingdom, France, Italy, Spain and the Rest of Europe are considered for the market analysis.

MARKET INSIGHTS

The rise in disposable income and high awareness about the benefits of sleep aids is expected to further fuel the market growth in this region. Germany is one of the major economies with a strong population in millions, the presence of high-quality healthcare infrastructure, and favorable reimbursement policies. It is one of the major medical tourism destinations in Europe and hence caters to the healthcare needs of other European nations.

COMPETITIVE INSIGHTS

The major market players operating in Europe are Koninklijke Philips N.V. (Philips), GE Healthcare, Teleflex, Fisher & Paykel Healthcare, CareFusion (Merged With Becton Dickinson), Invacare Corp., Smiths Group PLC (Smiths Medical), Braebon Medical Corporation, Medtronic PLC, Somnomedics, Itamar Medical Ltd., Nihon Kohden Corporation, Cadwell, Drive Devilbiss Healthcare and Resmed Inc.

Table of Contents
Product Code: 24169

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. POLYSOMNOGRAPHY DEVICE (PSG) HOLDS THE LARGEST MARKET SHARE IN TERMS OF DIAGNOSTIC MARKET
    • 3.2.2. HOSPITAL & SLEEP LAB DOMINATED THE GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTICS MARKET
    • 3.2.3. ORAL APPLIANCES ARE THE FASTEST GROWING THERAPEUTIC

4. MARKET DETERMINANTS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASE IN THE INCIDENCE OF OBESITY
    • 4.2.2. INCREASING GERIATRIC POPULATION
    • 4.2.3. INCREASE IN NUMBER OF SHIFT WORKERS
    • 4.2.4. RISING PREVALENCE OF SLEEP APNEA
    • 4.2.5. TECHNOLOGICAL ADVANCEMENTS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF SLEEP APNEA DIAGNOSTIC DEVICES
    • 4.3.2. LACK OF AWARENESS OF THE SLEEP APNEA DISORDER
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. INCREASE IN THE DEVELOPMENT OF SLEEP MEDICATION TO REDUCE SIDE EFFECTS
    • 4.4.2. GROWING OCCURRENCE OF SLEEP APNEA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
  • 4.5. MARKET CHALLENGES
    • 4.5.1. PATENT EXPIRATIONS
    • 4.5.2. DEARTH OF PATIENT COMPLIANCE

5. MARKET BY DIAGNOSTIC AND THERAPEUTIC

  • 5.1. DIAGNOSTIC
    • 5.1.1. POLYSOMNOGRAPHY DEVICE (PSG)
    • 5.1.2. SLEEP APNEA SCREENING DEVICE
    • 5.1.3. ACTIGRAPHY MONITORING DEVICE
    • 5.1.4. RESPIRATORY POLYGRAPH
    • 5.1.5. OXIMETER
  • 5.2. THERAPEUTIC
    • 5.2.1. AIRWAY CLEARANCE SYSTEMS
    • 5.2.2. ADAPTIVE SERVO -VENTILATION SYSTEMS
    • 5.2.3. POSITIVE AIRWAY PRESSURE (PAP) DEVICE
    • 5.2.4. ORAL APPLIANCES
    • 5.2.5. OXYGEN DEVICES
    • 5.2.6. OTHER THERAPEUTIC

6. MARKET BY END-USER

  • 6.1. HOSPITALS & SLEEP LABORATORIES
  • 6.2. HOME CARE SETTINGS

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCES MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF BUYERS
    • 7.1.4. BARGAINING POWER OF SUPPLIERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. REGULATORY FRAMEWORK
  • 7.3. PETL ANALYSIS
  • 7.4. MARKET TRENDS
  • 7.5. OPPORTUNITY MATRIX

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. GERMANY
    • 8.1.2. FRANCE
    • 8.1.3. THE UNITED KINGDOM
    • 8.1.4. ITALY
    • 8.1.5. SPAIN
    • 8.1.6. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

  • 9.1. MARKET POSITION ANALYSIS
  • 9.2. COMPANY PROFILES
    • 9.2.1. BRAEBON MEDICAL CORPORATION
    • 9.2.2. CADWELL
    • 9.2.3. CAREFUSION (MERGED WITH BECTON DICKINSON)
    • 9.2.4. DRIVE DEVILBISS HEALTHCARE
    • 9.2.5. FISHER & PAYKEL HEALTHCARE
    • 9.2.6. GE HEALTHCARE
    • 9.2.7. INVACARE CORP
    • 9.2.8. ITAMAR MEDICAL LTD.
    • 9.2.9. KONINKLIJKE PHILIPS N.V. (PHILIPS)
    • 9.2.10. MEDTRONIC PLC
    • 9.2.11. NIHON KOHDEN CORPORATION
    • 9.2.12. RESMED INC.
    • 9.2.13. SMITHS GROUP PLC (SMITHS MEDICAL)
    • 9.2.14. SOMNOMEDICS
    • 9.2.15. TELEFLEX

TABLE LIST

  • TABLE 1 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 2 PREVALENCE OF SLEEP APNEA 2015
  • TABLE 3 PREVALENCE OF COPD
  • TABLE 4 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC DEVICE 2019-2027 ($ MILLION)
  • TABLE 5 EUROPE POLYSOMNOGRAPHY DEVICE (PSG) MARKET 2019-2027 ($ MILLION)
  • TABLE 6 EUROPE SLEEP APNEA SCREENING DEVICE MARKET 2019-2027 ($ MILLION)
  • TABLE 7 EUROPE ACTIGRAPHY MONITORING DEVICE MARKET 2019-2027 ($ MILLION)
  • TABLE 8 EUROPE RESPIRATORY POLYGRAPH MARKET 2019-2027 ($ MILLION)
  • TABLE 9 EUROPE OXIMETER MARKET 2019-2027 ($ MILLION)
  • TABLE 10 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC DEVICE 2019-2027 ($ MILLION)
  • TABLE 11 EUROPE AIRWAY CLEARANCE SYSTEMS MARKET 2019-2027 ($ MILLION)
  • TABLE 12 EUROPE ADAPTIVE SERVO -VENTILATION SYSTEMS MARKET 2019-2027 ($ MILLION)
  • TABLE 13 EUROPE POSITIVE AIRWAY PRESSURE (PAP) DEVICE MARKET 2019-2027 ($ MILLION)
  • TABLE 14 EUROPE ORAL APPLIANCES MARKET 2019-2027 ($ MILLION)
  • TABLE 15 EUROPE OXYGEN DEVICES MARKET 2019-2027 ($ MILLION)
  • TABLE 16 EUROPE OTHER THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 17 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 18 EUROPE HOSPITALS & SLEEP LABORATORIES MARKET 2019-2027 ($ MILLION)
  • TABLE 19 EUROPE HOME CARE SETTINGS MARKET 2019-2027 ($ MILLION)
  • TABLE 20 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 21 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 22 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 23 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 24 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 25 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 26 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 27 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 28 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 29 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 30 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 31 SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC COMPANY MARKET POSITION ANALYSIS 2017

FIGURES LIST

  • FIGURE 1 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY DIAGNOSTIC 2018 & 2027 (%)
  • FIGURE 3 EUROPE SLEEP APNEA DIAGNOSTIC MARKET BY POLYSOMNOGRAPHY DEVICE (PSG) 2019-2027 ($ MILLION)
  • FIGURE 4 EUROPE SLEEP APNEA DIAGNOSTIC MARKET BY SLEEP APNEA SCREENING DEVICE 2019-2027 ($ MILLION)
  • FIGURE 5 EUROPE SLEEP APNEA DIAGNOSTIC MARKET BY ACTIGRAPHY MONITORING DEVICE 2019-2027 ($ MILLION)
  • FIGURE 6 EUROPE SLEEP APNEA DIAGNOSTIC MARKET BY RESPIRATORY POLYGRAPH 2019-2027 ($ MILLION)
  • FIGURE 7 EUROPE SLEEP APNEA DIAGNOSTIC MARKET BY OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 8 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTICS MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
  • FIGURE 9 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY AIRWAY CLEARANCE SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 10 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY ADAPTIVE SERVO -VENTILATION SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 11 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY POSITIVE AIRWAY PRESSURE (PAP) DEVICE 2019-2027 ($ MILLION)
  • FIGURE 12 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY ORAL APPLIANCES 2019-2027 ($ MILLION)
  • FIGURE 13 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY OXYGEN DEVICES 2019-2027 ($ MILLION)
  • FIGURE 14 EUROPE SLEEP APNEA THERAPEUTIC MARKET BY OTHER THERAPEUTIC 2019-2027 ($ MILLION)
  • FIGURE 15 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 16 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITALS & SLEEP LABORATORIES 2019-2027 ($ MILLION)
  • FIGURE 17 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOME CARE SETTINGS 2019-2027 ($ MILLION)
  • FIGURE 18 PORTER'S FIVE FORCE MODEL
  • FIGURE 19 GERMANY SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 20 FRANCE SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 21 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 ITALY SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 23 SPAIN SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 24 REST OF EUROPE SLEEP APNEA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)
Back to Top